While the p-value was 0.099, indicating a marginal significance, there still existed a noticeable trend suggesting that HCC patients with higher TET2 expression tended to have shorter survival times than those with lower levels (Fig. 5b). This evidence concerns the gene TET2 and hepatocellular carcinoma.